Pharmacotherapy in COVID-19; A narrative review for emergency providers
N Mehta, M Mazer-Amirshahi, N Alkindi… - The American journal of …, 2020 - Elsevier
Introduction The COVID-19 pandemic has been particularly challenging due to a lack of
established therapies and treatment guidelines. With the rapid transmission of disease, even …
established therapies and treatment guidelines. With the rapid transmission of disease, even …
Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review
JM Sanders, ML Monogue, TZ Jodlowski, JB Cutrell - Jama, 2020 - jamanetwork.com
Importance The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an …
Clinical management of COVID-19: a review of pharmacological treatment options
AM Heustess, MA Allard, DK Thompson, PS Fasinu - Pharmaceuticals, 2021 - mdpi.com
Since the outbreak and subsequent declaration of COVID-19 as a global pandemic in March
2020, concerted efforts have been applied by the scientific community to curtail the spread of …
2020, concerted efforts have been applied by the scientific community to curtail the spread of …
Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis
Background Numerous clinical trials and observational studies have investigated various
pharmacological agents as potential treatment for Coronavirus Disease 2019 (COVID-19) …
pharmacological agents as potential treatment for Coronavirus Disease 2019 (COVID-19) …
Treatment considerations for COVID-19: a critical review of the evidence (or lack thereof)
The novel severe acute respiratory syndrome coronavirus 2 is causing a worldwide
pandemic that may lead to a highly morbid and potentially fatal coronavirus disease 2019 …
pandemic that may lead to a highly morbid and potentially fatal coronavirus disease 2019 …
Anti COVID-19 drugs: need for more clinical evidence and global action
Abstract The World Health Organization (WHO) called the outbreak of coronavirus infectious
disease-2019 (COVID-19) a “Public Health Emergency of International Concern”(PHEIC) …
disease-2019 (COVID-19) a “Public Health Emergency of International Concern”(PHEIC) …
Potential therapeutic options for COVID-19: current status, challenges, and future perspectives
C Sarkar, M Mondal, M Torequl Islam… - Frontiers in …, 2020 - frontiersin.org
The COVID-19 pandemic represents an unprecedented challenge for the researchers to
offer safe, tolerable, and effective treatment strategies for its causative agent known as …
offer safe, tolerable, and effective treatment strategies for its causative agent known as …
COVID-19: A review of the proposed pharmacological treatments
S Lam, A Lombardi, A Ouanounou - European journal of pharmacology, 2020 - Elsevier
The emerging pandemic of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …
[HTML][HTML] Medical management of COVID-19: evidence and experience
Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), and this infectious disease is termed COVID-19 in short. On a global scale …
(SARS-CoV-2), and this infectious disease is termed COVID-19 in short. On a global scale …
[HTML][HTML] Current treatment in COVID-19 disease: a rapid review
M Rodriguez-Guerra, P Jadhav, TJ Vittorio - Drugs in context, 2021 - ncbi.nlm.nih.gov
The world has faced the most challenging pandemic of the modern era, that of severe acute
respiratory syndrome coronavirus 2 infection, causing coronavirus disease and affecting …
respiratory syndrome coronavirus 2 infection, causing coronavirus disease and affecting …